Perrigo Company plc ($PRGO) Stock Forecast: Down 5.1% Today

What is Perrigo Company plc?

Perrigo Company plc (PRGO) operates in the pharmaceutical sector, specializing in self-care products. The stock faced a notable downward trend in a day marked by overall negative market performance.

Why is Perrigo Company plc going down?

PRGO stock is down 5.1% on Mar 20, 2026 15:45

• Perrigo lagged behind its competitors and major market indices such as the S&P 500 and Dow Jones Industrial Average, causing a bearish shift in its stock.
• The decrease in ownership share by Ion Asset Management Ltd. potentially exerted downward pressure on the stock, indicating a lack of faith in Perrigo's future outlook.
• Despite positive company updates regarding advancements in its "Three-S" strategy and growth in core business shares, external factors and market sentiment appeared to overshadow these successes, leading to the stock's decline.
• A revision in the price target by Canaccord analyst Susan Anderson, despite acknowledging growth in Perrigo's primary operations, may have also impacted investor confidence and contributed to the downward momentum.

PRGO Price Chart

PRGO Technical Analysis

PRGO News

Perrigo Company plc (PRGO) Reports $1.06B Q2 Sales, Advances ‘Three-S’ Strategy

Perrigo Company plc (PRGO) has announced its second-quarter sales reached $1.06 billion, demonstrating continued progress in its "Three-S" strategy focused on Supply Chain, Structure, and Strategy. The company has also achieved significant milestones, including the successful completion of the U.S. launch of Opill and the full integration of its previously acquired HRA Pharma acquisition. These achievements are bolstering the company's position in the self-care market.

http://www.msn.com/en-us/money/savingandinvesting/perrigo-company-plc-prgo-reports-1-06b-q2-sales-advances-three-s-strategy/ar-AA1MPjh1?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1

Perrigo Co. PLC stock underperforms Wednesday when compared to competitors

Perrigo Co. PLC (PRGO) experienced a 3.50% decline in its stock price on Wednesday, closing at $9.94. This underperformance occurred during a generally negative trading session where both the S&P 500 Index and Dow Jones Industrial Average also saw significant declines. The stock's fall ended a two-day winning streak for Perrigo.

https://www.marketwatch.com/data-news/perrigo-co-plc-stock-underperforms-wednesday-when-compared-to-competitors-79277ffc-be84b35f65e1?mod=mw_quote_news&gaa_at=eafs&gaa_n=AWEtsqeWZ7AluTXnerHYV-ezm-tUw9t9Sabb9bcO_rtiRuiTY1AeDd6YuObf&gaa_ts=69bc70aa&gaa_sig=UVjJsJwUBFVGGXzvLfDrkvwPomE0N7pUDrIMc1Cb8KHBfRWC5wic2QtnJoHNem9FEmn0WQJHb3YaQB9uK6qnoQ%3D%3D

Perrigo (PRGO) director Bradley Alford awarded 3,024 RSUs vesting in 2027

Perrigo Company plc director Bradley A. Alford was granted 3,024 Restricted Stock Units (RSUs) as equity compensation, with each unit representing a contingent right to receive one ordinary share. These RSUs are scheduled to vest on March 13, 2027, and are a standard compensation-related award rather than an open-market transaction. Following this grant, Alford directly holds 3,024 RSUs and 41,160.148 ordinary shares in PRGO.

https://www.stocktitan.net/sec-filings/PRGO/form-4-perrigo-co-plc-insider-trading-activity-4e3dbea56ae7.html

Canaccord’s Susan Anderson Trims Perrigo (PRGO) Target but Notes Share Gains in Core Business

Canaccord analyst Susan Anderson has trimmed the price target for Perrigo Company plc (NYSE:PRGO) from $20 to $17, while maintaining a Buy rating. This adjustment comes despite Perrigo reporting share gains in both private label and branded businesses for Q4 2025 and the full year, although the infant nutrition segment remained soft. The company's CEO noted significant progress in 2025 across its portfolio, supported by distribution gains and market share improvements, and announced plans to sell its Dermacosmetics business.

https://www.insidermonkey.com/blog/canaccords-susan-anderson-trims-perrigo-prgo-target-but-notes-share-gains-in-core-business-1717972/?amp=1

Ion Asset Management Ltd. Sells 2,057,621 Shares of Perrigo Company plc $PRGO

Ion Asset Management Ltd. significantly reduced its stake in Perrigo Company plc (NYSE:PRGO) by 53.9%, selling over 2 million shares and now holding 1.76 million shares, making PRGO its seventh-largest position. The institutional investor's remaining stake is valued at approximately $39.2 million. This move comes as Perrigo announced a quarterly dividend of $0.29 per share, yielding 12.5%, and reported Q3 EPS of $0.77, missing estimates, with FY2026 guidance set at $2.25-$2.55 EPS.

https://www.marketbeat.com/instant-alerts/filing-ion-asset-management-ltd-sells-2057621-shares-of-perrigo-company-plc-prgo-2026-03-16/

Trending Today

Mosaic Company (The) ($MOS) Stock Forecast: Down 9.3% Today

QuantumScape Corp. ($QS) Stock Forecast: Down 5.5% Today

FuelCell Energy ($FCEL) Stock Forecast: Down 5.4% Today

Peloton Interactive Inc ($PTON) Stock Forecast: Down 5.7% Today

Kimco Realty Corporation ($KIM) Stock Forecast: Down 3.5% Today

SL Green Realty Corp ($SLG) Stock Forecast: Down 5.2% Today

StoneCo Ltd. ($STNE) Stock Forecast: Down 5.2% Today

Cleveland-Cliffs Inc. ($CLF) Stock Forecast: Down 5.0% Today

American Airlines Group Inc. ($AAL) Stock Forecast: Down 5.4% Today

TKO Group Holdings Inc ($TKO) Stock Forecast: Down 5.2% Today

Perrigo Company plc Price History

20.01.2026 - PRGO Stock was up 0.1%

• The strong bullish movement in PRGO today can be attributed to the announcement of a quarterly dividend of $0.29 per share, showcasing the company's commitment to rewarding shareholders even amidst financial challenges.
• Despite the expected decline in Q4 earnings and revenues, investors seem optimistic about Perrigo's future prospects, especially with a 44% upside potential according to valuation insights.
• The focus on being a pure-play consumer health company and the emphasis on private-label offerings to invest in leading brands might have resonated positively with investors, driving the bullish sentiment in the stock today.

03.02.2026 - PRGO Stock was down 8.5%

• Perrigo Company plc (PRGO) received a consensus "Hold" rating from analysts, with a lower-than-expected 12-month price target.
• Despite increased stakes from major investors like Bahl & Gaynor Inc. and Vanguard Group Inc., Perrigo missed Q4 EPS estimates and issued weaker FY2026 guidance, citing challenges in the infant formula segment.
• The company discussed its Q4 earnings, acknowledging temporary headwinds such as a soft cough and cold season and plant underabsorption, leading to a transition year in 2026.
• Analysts, including Jefferies, maintained a "Hold" rating on PRGO, signaling a cautious approach and a wait-and-see attitude towards operational improvements.

05.00.2026 - PRGO Stock was up 1.9%

• Perrigo's stock experienced a bullish movement despite facing multiple class action lawsuits related to its infant formula business.
• Investors seem hopeful about Perrigo's ability to address the legal challenges and recover financially.
• The positive stock performance could be due to expectations of Perrigo implementing corrective measures to improve transparency and governance.
• There is a perception among investors that the lawsuits are temporary obstacles that Perrigo can overcome, bolstering confidence in the company's long-term outlook.

25.10.2025 - PRGO Stock was up 5.5%

• Despite facing various legal challenges, PRGO stock showed a significant upward movement.
• Investors may be interpreting potential advancements in the legal cases against Perrigo Company plc in a positive light.
• The stock's bullish trend could also be influenced by market speculations or a change in investor sentiment driven by factors not explicitly mentioned elsewhere.
• Staying informed about updates on legal proceedings and market dynamics is crucial for making well-informed decisions concerning PRGO stock.

26.01.2026 - PRGO Stock was down 1.1%

• The bearish movement in Perrigo's stock price today could be attributed to the cautious outlook from analysts regarding the upcoming Q4 earnings, which is expected to show a decline in both EPS and revenue.
• The planned divestiture of Perrigo's rare disease affiliate for $294 million could be seen as a strategic move to focus on its core consumer goods business, but investors might be concerned about the impact on future revenue streams.
• Despite the positive news of a quarterly dividend announcement, the overall sentiment seems to be overshadowed by the upcoming earnings report and the company's recent performance, leading to the bearish market movement today.

20.02.2026 - PRGO Stock was down 5.1%

• Perrigo lagged behind its competitors and major market indices such as the S&P 500 and Dow Jones Industrial Average, causing a bearish shift in its stock.
• The decrease in ownership share by Ion Asset Management Ltd. potentially exerted downward pressure on the stock, indicating a lack of faith in Perrigo's future outlook.
• Despite positive company updates regarding advancements in its "Three-S" strategy and growth in core business shares, external factors and market sentiment appeared to overshadow these successes, leading to the stock's decline.
• A revision in the price target by Canaccord analyst Susan Anderson, despite acknowledging growth in Perrigo's primary operations, may have also impacted investor confidence and contributed to the downward momentum.

04.01.2026 - PRGO Stock was up 5.5%

• The announcement of Perrigo's strategic review of its infant formula business has sparked investor optimism and contributed to the bullish movement in PRGO stock.
• Investors likely view this move as a proactive step towards enhancing Perrigo's overall portfolio and focusing on high-potential OTC products, which are more aligned with the company's strategic goals.
• The decision to re-evaluate a significant investment in the infant formula business, coupled with the emphasis on accelerating cash flows, signals a commitment to optimizing resources and maximizing returns for shareholders.
• By streamlining its operations and reallocating resources to areas with higher growth potential, Perrigo aims to strengthen its position in the market and drive long-term value creation, which has resonated positively with investors.

06.10.2025 - PRGO Stock was down 8.2%

• PRGO posted Q3 earnings exceeding expectations but underperformed in sales, resulting in a mixed outcome.
• Following a downward revision of its 2025 outlook and the initiation of a review of its infant formula unit, investor worries about future growth prospects were sparked, leading to a decline in the stock price.
• Despite surpassing earnings expectations, PRGO faced a notable bearish movement in the stock market due to negative reactions to the uncertainty surrounding the company's strategic decisions.

17.02.2026 - PRGO Stock was up 7.8%

• Despite adjustments to PRGO's price target by an analyst, the company revealed increased share gains in its key sectors during Q4 2025, demonstrating strength and room for growth.
• Even though two investment firms reduced their stakes in PRGO, the rise in positions by other hedge funds signals confidence in the company's future performance.
• PRGO's decision to sell its Dermacosmetics business could be viewed as a strategic maneuver to enhance operational efficiency and concentrate on its core competencies, which could positively impact investor confidence.
• Conversations about PRGO's stock performance post-earnings report reflect market fluctuations and raise the possibility of a buying opportunity as investors evaluate the potential for a stock price rebound.

19.10.2025 - PRGO Stock was down 5.1%

• The securities fraud class action lawsuit filed against Perrigo Company plc might have created uncertainty and negative sentiment among investors, leading to a sell-off of PRGO shares.
• The reminder to investors about the ongoing class action lawsuits against Perrigo Company plc could have further fueled concerns and prompted more selling pressure on the stock.
• The legal challenges and potential financial implications from the lawsuits may have overshadowed any positive developments or fundamentals related to Perrigo Company plc, contributing to the bearish market movement of PRGO today.

12.02.2026 - PRGO Stock was down 5.0%

• The increased stake by institutional investors like Dimensional Fund Advisors LP and BW Gestao de Investimentos Ltda. could indicate confidence in Perrigo's long-term prospects, yet the market reacted negatively.
• Despite the company's declaration of a quarterly dividend and analysts' "Hold" rating with a price target of $19.33, investors might be concerned about other factors impacting the stock.
• The bearish movement could be attributed to broader market conditions, sector-specific challenges, or specific company developments not shared widely.
• Investors may be reacting to potential risks or uncertainties surrounding Perrigo, leading to the downward pressure on the stock price despite the positive institutional investment activities.

27.01.2026 - PRGO Stock was down 2.5%

• PRGO stock experienced a significant bearish movement today, dropping by 6.7% in pre-market trading.
• The bearish trend can be attributed to the Q4 2025 earnings report where both adjusted EPS and revenue missed analyst estimates, leading to investor disappointment.
• Despite management highlighting strategic progress and market share gains, investors focused on the immediate financial shortfall, causing the stock price to decline.
• The upcoming ex-dividend date and historical dividend charts may have influenced some investors to sell off their positions, contributing to the downward pressure on PRGO stock.